Meet ApplyKite Twin, the application assistant that learns with you
Meet your Twin, it learns with you
Your Twin learns with you
Launch week codes:30% off annual Pro20% off monthly Pro
Ends in00h00m00s
Ends in00h00m00s
US Food and Drug Administration
Just Landed
New Today
FDA Pediatric Extrapolation: Analysis Using FDA Clinical Trial Data U.S. Food and Drug Administration (FDA) in United States
Degree Level
Master's
Field of study
Biology
Funding
Monthly stipend commensurate with educational level and experience; appointment initially for one year and renewable subject to FDA recommendation and availability of funds.
Deadline
Dec 11, 2026
Country
United States
University
US Food and Drug Administration
Apply for this position
Keywords
Suggested positions
About this position
This research opportunity is based in the U.S. Food and Drug Administration’s Center for Drug Evaluation and Research (CDER), within the Office of Rare Diseases, Pediatrics, Urologic and Reproductive Medicine and the Division of Pediatrics and Maternal Health in Silver Spring, Maryland. The project is part of FDA’s broader effort to ensure safe and effective drugs for children and adults, using the agency’s access to extensive pediatric clinical trial data.
The selected participant will work on pediatric extrapolation research, examining how evidence from adult studies can inform pediatric drug development when disease characteristics, pharmacology, and treatment responses appear similar across age groups. The project focuses on analyzing adult and pediatric clinical trial data to assess assumptions underlying extrapolation for selected diseases or conditions, with attention to pharmacokinetics, efficacy, and safety.
Training within the opportunity includes data collection from public and proprietary sources, data analysis and interpretation, and preparation of findings for scientific dissemination and publication. The participant will also contribute to a systematic review of adult and pediatric clinical trial data and help evaluate the potential to leverage prior studies to optimize future trials. The role is hybrid, with some in-person work at the FDA White Oak Campus.
Funding details
Monthly stipend commensurate with educational level and experience; appointment initially for one year and renewable subject to FDA recommendation and availability of funds.
What's required
The qualified candidate should be currently pursuing or have received a Master's or Doctoral degree in a relevant field. The degree must have been received within five years of the appointment start date, or the applicant must be currently pursuing it. This opportunity is available only to U.S. citizens and Lawful Permanent Residents (LPRs). All documents must be in English or include an official English translation. A successful background investigation by the Office of Personnel Management is required, and applicants must have lived in the United States for at least 36 of the past 60 months for the background investigation requirement to be completed.
How to apply
Scroll to the bottom of the opportunity page and click APPLY. Submit an application, transcripts, a current resume/CV, and one educational or professional recommendation. If you have questions, email [email protected] and include the reference code FDA-CDER-2026-0188.
Make your next move.
Prepare your application
Review drafts and confirm requirements with the university.
Make your next move.
Prepare your application
Review drafts and confirm requirements with the university.